جست‌وجوی استاد و پژوهشگر

• Coronavirus Immunology
• Viral Immunology
• Veterinary Pathology
• +۷ مورد دیگر

Rudra Channappanavar, DVM, PhD is an Associate Professor in Viral Immunology and Veterinary Pathology at the College of Veterinary Medicine, Oklahoma State University. He also serves as faculty for the Oklahoma Center for Respiratory and Infectious Diseases (OCRID). His research focuses on coronavirus-host interactions, mechanisms of protective and pathogenic immunity, and development of antiviral therapeutics. Dr. Channappanavar earned his DVM from Veterinary College, KVAFSU, India, his MVSc in Veterinary Pathology from Indian Veterinary Research Institute, and his PhD in Biology with a focus on Immunology and Infectious Diseases from Oakland University. He completed postdoctoral training at the University of Iowa in Coronavirus Immunobiology and Virology. His research program has three primary focuses: (1) Understanding coronavirus-host interactions and mechanisms of protective and pathogenic immunity, using in vitro and in vivo approaches including knockout and transgenic mouse models; (2) Improving immune responses to human coronavirus infections and vaccinations in the elderly, investigating the role of interferons and monocytes-macrophages in age-related susceptibility; and (3) Identifying and evaluating antiviral and anti-inflammatory agents to reduce coronavirus disease severity, with work on compounds like Camostat Mesylate and amniotic fluid-derived extracellular vesicles. Analysis of his recent publications (2021-2025) reveals a strong focus on SARS-CoV-2 pathogenesis, particularly investigating TLR-mediated immune responses, macrodomain functions in viral replication, and therapeutic approaches including nanoliposome drug delivery systems. His work spans basic molecular virology to translational therapeutic development, with a consistent emphasis on understanding dysregulated immunity in severe coronavirus disease. Dr. Channappanavar has secured significant funding for his research, including multiple NIH grants such as 'Role of ERK1/2 signaling in SARS-CoV-2-induced dysregulated immunity and lung pathology' (2024-2029) and 'Myeloid cell TRAF6 signaling in SARS-CoV-2-induced dysregulated lung immunity' (2024-2026). He also contributes to the Oklahoma Center for Respiratory and Infectious Diseases (OCRID), a NIH-funded Center of Biomedical Research Excellence (CoBRE). As an educator, he teaches PhD Research and Dissertation courses and Undergraduate Research Problems, mentoring the next generation of veterinary and biomedical researchers. His laboratory serves as an important training ground for students interested in viral immunology and respiratory infectious diseases.

Enrico Milloمشاهده پروفایل

دانشیار

• Biochemistry
• Molecular Biology
• Pharmacology
• +۳ مورد دیگر

Enrico Millo is an Associate Professor at the University of Genova, affiliated with the Department of Experimental Medicine (DIMES). His teaching portfolio includes Biochemistry and Biological Chemistry courses across multiple degree programs such as Nursing, Medicine and Surgery, and Medical-Pharmaceutical Biotechnology. Research interests span blood-brain barrier permeability , SIRT enzyme inhibition , cystic fibrosis drug development , and targeted cancer therapies . Recent work focuses on computational drug discovery, peptide engineering, and modulation of cellular signaling pathways. Key publications highlight expertise in Designing peptides to enhance blood-brain barrier permeability Developing SIRT1/2 inhibitors using computational methods Optimizing multi-drug approaches for cystic fibrosis Exploring thiazole-based compounds for anticancer activity Targeting PI3Kγ for pulmonary cAMP modulation

• Immunology
• Cancer Immunotherapy
• Natural Killer Cell Biology
• +۴ مورد دیگر

Chiara Vitale is an Associate Professor at the University of Genoa , affiliated with the Department of Experimental Medicine (DIMES) . Her teaching responsibilities span multiple degree programs including Pharmacy , Physiotherapy , Medical-Pharmaceutical Biotechnology , and Nursing , where she delivers courses on Immunology , General Pathology , and Molecular Pathology . Academic Focus : Experimental Medicine, Immunology, and Pathology Teaching Portfolio : 8+ courses across single-cycle and undergraduate programs Research Themes : NK cell biology, cancer immunotherapy, drug effects on immune surveillance Her research explores the intersection of innate immunity and hematopoietic therapies , with recent work analyzing epigenetic modulators like Guadecitabine and EZH1/2 inhibitors. She also investigates murine models for NK cell function in solid tumors and cord blood-derived NK cells for clinical applications. Vitale's publications reflect a trajectory from foundational ILC3 development studies (2021) to translational work on targeted cancer therapies (2020). No scientific awards are documented in the provided text. She is available for consultation in Genoa via email at chiara.vitale@unige.it and continues active research in NK cell-based immunotherapies.

• Drug Delivery
• Polymer Chemistry
• Nanomedicine
• +۳ مورد دیگر

Joshua Morrow serves as a Research Fellow at Monash University within the Drug Delivery Disposition & Dynamics research group. His work focuses on advanced polymer-based drug delivery systems, particularly utilizing poly(2-oxazoline) and poly(2-oxazine) platforms for targeted therapeutic applications in nanomedicine and pharmaceutical sciences. His research centers on designing water-soluble polymers for enhanced drug stability and delivery efficiency. Key investigations include blood-brain barrier penetration mechanisms for brain cancer therapy, chirality effects on nanoparticle-protein interactions, and development of novel lipid alternatives for mRNA delivery. Morrow's work bridges polymer chemistry with biomedical applications to address critical challenges in drug formulation and delivery. Analysis of his 2024 publications reveals concentrated innovation in poly(2-oxazoline) derivatives, with significant contributions to hydrophilicity characterization, blood-brain barrier crossing enhancement, protein corona modulation, antiferroptosis drug conjugates, and mRNA-lipid nanoparticle stabilization. These studies demonstrate systematic advancement in biomaterial design for next-generation therapeutics. No scientific awards were mentioned in the provided information. Details regarding student advising and research grant funding were not specified in the available materials. Morrow operates within Monash University's Drug Delivery Disposition & Dynamics group, maintaining extensive collaboration with the Kempe research team and international partners across polymer synthesis, nanomedicine development, and therapeutic application testing.

Martin Beukemaمشاهده پروفایل

پژوهشگر

• Mucosal Immunology
• Vaccinology
• Respiratory Virus Vaccines
• +۵ مورد دیگر

Dr. Martin Beukema is a Postdoctoral Researcher at the University of Groningen's Faculty of Medical Sciences, affiliated with both the Translational Immunology Groningen (TRIGR) and Microbes in Health and Disease (MHD) research groups. He currently works in the Department of Molecular Pharmacology under Prof. A.L.W. Huckriede and Prof. B.N. Melgert, focusing on developing lung organoid models for respiratory virus vaccine research. Dr. Beukema's research interests center on mucosal immunology, vaccinology, and the relationship between dietary components and immune function. His work spans respiratory virus vaccines, organoid models, mucosal immunity, and the immunological effects of pectin structures. He has made significant contributions to understanding how vaccine delivery methods impact immune responses and how dietary fibers influence intestinal immunity. His recent publications demonstrate a strong focus on influenza vaccine development, with particular emphasis on novel delivery systems like microneedles and sustained-release formulations. His work also explores the development and comparison of in vitro models for studying respiratory infections, including air-liquid interface systems and organoid models. Additionally, his research on pectin structure-function relationships has contributed to understanding how dietary fibers can modulate gut immunity. Global Prebiotic Association Young Researcher Grant (2022) Dr. Beukema actively supervises bachelor's and master's students in laboratory skills, thesis writing, and poster preparation. He has been involved in numerous research projects funded through academic grants and collaborations with industry partners. His teaching activities include lectures on future vaccination strategies, mucosal in vitro models for respiratory virus vaccines, and immunology of infection for both bachelor's and master's programs at the University of Groningen. He is part of the Translational Immunology Groningen (TRIGR) and Microbes in Health and Disease (MHD) research teams, which focus on understanding immune responses to pathogens and developing novel vaccine strategies. His current work on lung organoid models represents a cutting-edge approach to studying respiratory virus infections and vaccine development.

• Medicinal Chemistry
• Pharmacology
• Toxicology
• +۳ مورد دیگر

Einsiedel J., a part-time lecturer at the Department of Chemistry and Pharmacy within Friedrich-Alexander University Erlangen-Nürnberg's Faculty of Natural Sciences, contributes to pharmaceutical education through the Chair of Pharmaceutical Chemistry (led by Prof. Dr. Gmeiner). They coordinate practical training modules in drug analysis and toxicological investigations. Focus on applied pharmaceutical chemistry and laboratory safety Teaching modules include drug monitoring, environmental analysis, and GHS compliance Associated with the Chemikum laboratory facilities

Sean N Avedissianمشاهده پروفایل

دانشیار

• Pharmacokinetics
• Antibiotic Modeling
• Antiviral Therapy
• +۳ مورد دیگر

Sean N Avedissian, PharmD, MSc, PhD is an Associate Professor in the Department of Pharmacy Practice and Science at the University of Nebraska Medical Center's College of Pharmacy. His academic appointment focuses on pharmacokinetic research and teaching in infectious disease pharmacology. Dr. Avedissian's research interests center on pharmacokinetic modeling of antibiotics and antivirals in special populations, particularly those with HIV and critically-ill patients. His work encompasses developing pharmacokinetic models in both clinical and pre-clinical environments, investigating drug mass transit from plasma to other body compartments, and examining how patient-specific variables affect pharmacokinetics. His laboratory has been actively integrating with the HIV/TB research group to develop mathematical models describing the pharmacokinetics of HIV/TB drugs. Teaching activities include lecturing in Infectious Disease and Pharmacokinetics courses at the College of Pharmacy. His recent publications (2023-2025) demonstrate strong research productivity in antibiotic pharmacokinetics, antiviral CNS penetration, and modeling approaches for special populations. His scholarly output spans diverse areas including: Pharmacokinetic modeling in critically-ill patients Antibiotic and antiviral distribution in special populations Drug penetration across the blood-brain barrier Population pharmacokinetics in pediatric and HIV populations Mathematical modeling of drug distribution

May Abdelazizمشاهده پروفایل

استادیار

• Drug Discovery
• Kinase Enzymology
• Allosteric Modulators
• +۴ مورد دیگر

Dr. May Abdelaziz is an Assistant Professor in the Pharmaceutical Sciences Department at the Ben and Maytee Fisch College of Pharmacy, The University of Texas at Tyler. She earned a BPharm (2002) and MS (2008) from Cairo University, followed by a PhD in Pharmaceutical Sciences from Virginia Commonwealth University (2013). She completed postdoctoral training at the University of Utah (2013-2014) and UCSF (2015-2017). Dr. Abdelaziz teaches medicinal chemistry in the PharmD curriculum and mentors students across academic levels. Her research focuses on kinase-targeted drug discovery with emphasis on allosteric modulators, enzyme kinetics, and protein-protein interactions. Current NIH-funded projects include: R15 Award (NCI): Developing allosteric HER2 inhibitors for breast cancer R21 Award (NIAID): Studying VraS kinase mutations in bacterial antibiotic resistance Bacterial histidine kinases as targets for resistance-modifying agents She has received multiple honors including: Dean’s Award for Excellence in Graduate Studies VCU 10 under 10 Award Graduate School Dissertation Award Teacher of the Year Award Dr. Abdelaziz leads an active research team investigating cancer therapeutics and bacterial resistance mechanisms, with recent publications spanning microbiology, medicinal chemistry, and pharmaceutical education.

Andrea Secchiمشاهده پروفایل

استاد

• Supramolecular Chemistry
• Molecular Recognition
• Nanoscience
• +۴ مورد دیگر

Andrea Secchi is a Full Professor in the Department of Chemical, Life and Environmental Sustainability Sciences at the University of Parma. He holds a Master's in Chemistry (1992) and a PhD in Chemical Sciences (1995) from the University of Parma. His research focuses on supramolecular chemistry, molecular recognition, and nanoscience, particularly involving calixarene-based systems, molecular machines, and functional nanomaterials. He has supervised over 60 theses and 8 PhD students in chemistry and materials science. His work bridges organic synthesis, materials science, and bioapplications, with over 94 peer-reviewed articles and a citation count exceeding 2,800. Education: PhD in Chemical Sciences, University of Parma (1995) Master's in Chemistry, University of Parma (1992) Research interests include calixarene functionalization for molecular machines, hybrid organic-inorganic nanomaterials, and NIR dye-plasmonic material interactions. His nanomaterials research spans gold/silver nanoparticles, magnetic nanoparticles, and self-assembled monolayers. Recent work explores applications in biosensing, drug delivery, and environmental analysis. Teaching roles since 2005 include courses in Physical Methods in Organic Chemistry, Organic Chemistry of Materials, and Environmental Chemistry at both undergraduate and graduate levels. Administrative roles include Chair of the Chemistry Course of Study Board, member of the Department Safety Committee, and international mobility committee. He collaborates with institutions in France, Germany, Belgium, and the UK on calixarene-based projects. Publications demonstrate expertise in calixarene derivatives, rotaxane/catenane synthesis, and nanomaterial functionalization. Over 2860 citations highlight impact in supramolecular and materials chemistry fields.

Boyoung Jeongمشاهده پروفایل

استاد آموزشی

• Geoenvironmental Engineering
• Biogeotechnical Engineering
• Flow in Porous Media
• +۴ مورد دیگر

Boyoung Jeong is an Assistant Teaching Professor in the Department of Civil, Architectural, and Environmental Engineering at Illinois Institute of Technology’s Armour College of Engineering. Her expertise spans geoenvironmental and biogeotechnical engineering, focusing on flow in porous media, bio-mediated geotechnics, and bio-geo materials. She holds a Ph.D. in Civil Engineering from Georgia Institute of Technology (2022), an M.S. and B.S. in Civil and Environmental Engineering from Seoul National University (2014, 2012). Research Interests: Her work addresses microbial influences on geotechnical systems, geomaterials characterization, and sustainable engineering solutions. Key areas include microbially induced calcite precipitation, motile bacterial effects in porous media, and biofilm-mediated material repair. These studies aim to enhance environmental sustainability and infrastructure resilience. Awards 2021 George F. Sowers Distinguished Graduate Student Award 2021 Regina Sanborn Outreach Award (NSF CBBG) 2020 Paul W. Mayne Award 2016–2018 Korean Government Scholarship Publications : Boyoung’s research explores bio-geochemical interactions in engineered systems. Recent work includes studies on bacterial effects on fluid displacement in porous media, surface tension dynamics, and self-healing concrete using microbial additives. Her publications span journals like Géotechnique and Water Research , emphasizing interdisciplinary approaches to environmental and geotechnical challenges. Contact: bjeong1@iit.edu | Office: Alumni Memorial Hall 228D

Sarah I. Rooneyمشاهده پروفایل

دانشیار

• Engineering Education
• Diversity, Equity, and Inclusion
• Engineering Design and Innovation
• +۲ مورد دیگر

Sarah I. Rooney serves as Associate Professor and Associate Chair of Biomedical Engineering Undergraduate Studies at the University of Delaware's College of Engineering, where she develops and teaches core curriculum courses including biomechanics, medical devices, and clinical immersion. Her teaching-focused appointment emphasizes continuous program improvement and industry-clinical integration through an NIH R25 grant-funded medical devices course. Her educational credentials include: Ph.D. in Bioengineering, University of Pennsylvania (2015) M.Sc. in Biomedical Engineering, University of Michigan (2010) B.S. in Biomedical Engineering, University of Michigan (2009) Dr. Rooney's research spans three interconnected domains: Engineering Education focusing on evidence-based instructional methods; Diversity, Equity, and Inclusion initiatives for inclusive engineering environments; and Engineering Design and Innovation addressing clinical unmet needs through student-clinician collaborations. Her foundational work examined musculoskeletal tissue responses to exercise and pharmaceuticals. Publication analysis reveals a strategic shift from biomechanics (2015-2018) toward educational scholarship (2019-2025), with recent work emphasizing inclusive pedagogy, curriculum innovation, and student engagement strategies in biomedical engineering education. Her accolades include: American Society for Engineering Education (ASEE) Biomedical Engineering Teaching Award (2018) University of Delaware College of Engineering Faculty Award for Excellence in Teaching (2022) ASEE Biomedical Engineering Division Best Work in Progress Award (2024) ASEE Faculty Development Division Best Diversity Paper Award (2020) ASEE Best Diversity, Equity & Inclusion Paper Award Finalist (2020) As NIH R25 grant PI, she directs curriculum development initiatives while mentoring undergraduate design teams through capstone projects. Her leadership extends to faculty development programs promoting inclusive teaching practices across engineering disciplines. Dr. Rooney actively collaborates with clinicians and industry partners through medical device design projects, maintaining strong connections between academic training and real-world engineering applications.

William E. Fantegrossiمشاهده پروفایل

استاد

• Synthetic Cannabinoids
• Opioid Abuse
• Drug Abuse Pharmacology
• +۳ مورد دیگر

William E. Fantegrossi is a Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences (UAMS), College of Medicine. His research focuses on emerging drugs of abuse, including synthetic cannabinoids, cathinones, hallucinogens, and novel opioids. He investigates their pharmacological profiles, toxicity mechanisms, and interactions with established drugs like fentanyl. Fantegrossi leads multiple funded projects, including NIH/NIDA grants exploring synthetic cannabinoid toxicity and ASPET fellowships for undergraduate training. His lab employs behavioral pharmacology techniques in rodents, assessing drug effects on locomotion, thermoregulation, and neurochemistry. He also directs the Behavioral Core of the Center for Translational Neuroscience. Education: Ph.D. in Pharmacology, University of Michigan, 2002 Research Interests: Pharmacology of synthetic cannabinoids (Spice/K2), cathinones (bath salts), and fentanyl analogues Abuse liability testing and neurotoxicity mechanisms Drug interactions contributing to overdose (e.g., fentanyl + cannabinoids) Development of novel therapeutic agents targeting addiction and neurological disorders Grants & Awards: DEA/FDA HHSF223201610079C (PI): In Vivo Pharmacological Studies for Abuse Liability Testing (2016-2021) NIH/NIDA R01 DA039143 (Co-I): Synthetic Cannabinoid Toxicity (2015-2020) NIH/NIGMS P30 GM110702: Behavioral Core Director (2014-2019) Labs & Teams: Leads a multidisciplinary team studying drug abuse mechanisms, including collaborations with chemists, toxicologists, and neuroscientists. His lab supports training programs for undergraduate and medical student researchers through T32 and ASPET fellowships.

David Gomez Varelaمشاهده پروفایل

پژوهشگر

• Proteomics
• Chronic Pain
• Microbiome Interactions
• +۴ مورد دیگر

Dr. David Gomez Varela is a Senior Scientist at the University of Vienna's Department of Pharmaceutical Sciences, affiliated with the Division of Pharmacology and Toxicology. He holds a permanent position and directs the University of Vienna-Bruker Center of Excellence for Metaproteomics. His roles include leading interdisciplinary projects in proteomics, machine learning, and personalized health solutions. Previously, he worked at UC San Diego and the Max Planck Institute for Experimental Medicine, where he developed novel proteomic techniques like Data Independent Acquisition (DIA). Education: PhD in Biochemistry from Oviedo University (Spain), postdoctoral research in ion channel electrophysiology and microscopy at the Max Planck Institute (Germany), and senior scientist roles in the US and Germany. Research focuses on chronic pain mechanisms, host-microbiome interactions, and microbiome-driven drug discovery. Key projects include CODOP/COEWS algorithms for predicting COVID-19 outcomes and the SaLux pocket PCR machine. Recent publications emphasize proteomic profiling of pain signatures, microbiome interactions, and age/sex differences in neural tissues. Currently leads a team deploying DIA-PASEF mass spectrometry, ML analysis, and mouse behavior studies to identify chronic pain targets. The Center of Excellence for Metaproteomics collaborates with Bruker to advance LC-MS and AI for microbiome studies in health ecosystems. Grants and advising: Directed international teams in pandemic response projects, validated >40,000 patient data. Active in mentoring postdocs and PhD students in proteomics and systems biology. Labs/Teams: Director of the Vienna-Bruker Center, leading the Pharmacology & Toxicology Division's proteomics initiatives. Collaborates globally on translational medicine projects.

• Intellectual Property
• Trade Secrets
• Data Privacy
• +۳ مورد دیگر

John Hull is a Teaching Fellow at Queen Mary University of London's School of Law, focusing on intellectual property transactions, trade secrets, and data privacy. He holds an LLB from Warwick and LLM from LSE, with extensive experience as a solicitor and partner at Dentons and Eversheds. His research critically examines commercial secrecy frameworks and regulatory challenges in technology transfer. Recent publications analyze compulsory licensing during health crises and EU trade secret legislation. Hull actively contributes to legal education as module leader for Commercialisation of IP and Trade Secrets courses, while consulting for international institutions on IP commercialization. Research interests center on the intersection of confidentiality, data protection, and innovation governance, particularly in academic-industry collaborations. Publications frequently address gaps between legal theory and business practice in IP management. Awards include recognition for pedagogical impact in postgraduate IP programs. Professional activities include visiting lectureships at King's College London and UCL, alongside advisory roles for patent attorney firms. Administrative responsibilities include curriculum development for IP practitioner certificates. Public engagement features conference presentations on research misconduct in medical fields and technology licensing models.

• Economic Evaluations
• Non Communicable Diseases
• Adolescent Health and Wellbeing
• +۴ مورد دیگر

Neelam Kalita is a Senior Research Fellow in Healthcare Modelling at Southampton Health Technology Assessments Centre (SHTAC), University of Southampton. She specializes in economic evaluations of health technologies and contributes to evidence reviews for NICE programs, spanning oncology, retinal conditions, and public health interventions. Her primary research focus includes adolescent health, non-communicable diseases, and global health equity. Her work history includes roles at a pharmaceutical consultancy firm and as a research assistant at the School of Health and Related Research (ScHARR), University of Sheffield. She collaborates with the MRC LEU on behavioral interventions to improve adolescent health outcomes. Neelam is affiliated with several University of Southampton campuses, including Highfield Campus and University Hospital Southampton. Neelam’s research publications (2021–2023) emphasize cost-effectiveness analyses of treatments for ulcerative colitis, multiple myeloma, uterine fibroids, and other conditions. These studies often intersect with pharmacoeconomics, gene therapy, and rare disease interventions. Her teaching contributions include the module MEDI6233: Health Economics for Public Health and training courses on health economics through SHTAC. No scientific awards are listed in her profile. She has supervised no formally registered PhD students, though her NIHR Pre-Doctoral Fellowship (2019–2021) funded £60,462 demonstrates prior research engagement. Current projects include the Engaging Adolescents in Changing Behaviour (EACH-B) initiative. Neelam is part of interdisciplinary research teams at SHTAC and collaborates with external groups like MRC LEU to advance healthcare modelling and global health strategies.